Juan Valle explains that some patients with neuroendocrine tumours suffer from carcinoid syndrome characterised by very specific symptoms. He stressed out why it is important to detect it, and details its physiopathology, how carcinoid syndrome should be managed and what are the available treatments.

Reprinted from:
Mamikunian G, et al, Neuroendocrine Tumors: A Comprehensive Guide to Diagnosis and Management. (4th ed.) Inglewood, CA: Inter Science Institute; 2009, with permission from InterScience Institute.
Daniel M Halperin et al., Lancet Oncol., Vol. 18(4), Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study, Pages 525-534, Copyright (2017), with permission from Elsevier.
Pavel M, et al., Neuroendocrinology, Vol. 103(2), ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site, Pages 172-85, Copyright (2016), with permission from Karger.
Jensen R. In: Harrison’s Principles of Internal Medicine Online. (17th ed) New York, NY: McGraw-Hill, Inc; Copyright (2008), with permission from McGraw-Hill Education.

Major Sponsors

AstraZeneca Bristol-Myers Squibb MSD Servier

Main Sponsors

Astellas Bayer Healthcare Boehringer Ingelheim Daiichi Sankyo ipsen Janssen logo Novartis Roche